Posts


HIV risk reduction via confidential unit exclusion (CUE): A retrospective analysis of four high ...

Human Immunodeficiency Virus ( HIV ) infection transmitted via multiple routes remains a persistent major challenge for global public health efforts ... View article...

Thailand's HIV Cases Cross 550,000 In 2026; Over 25,000 Among 15–24s

More than 83% of people receiving HIV care are on continuous antiretroviral treatment in the country, and have achieved effective viral ... View article...

India's HIV Revolution: From Saving the Global South to Shaping Its Future

From the first years of fear, stigma and therapeutic helplessness, we have moved to highly effective antiretroviral ... antiretrovirals could be ... View article...

New once-weekly HIV pill matches daily treatment in phase 3 trial

Living with HIV often means taking antiretroviral treatment every day to keep the virus under control. While modern HIV medicines have made it ... View article...

Study from Lichterfeld and Yu Labs Shows HIV Reservoirs are Visible to Immune System ...

Antiretroviral therapy can hold HIV in check for a lifetime, but it cannot clear it. A small number of infected cells carry a complete, ... View article...

Lenacapavir shot offers hope, but access is constrained

The twice-yearly HIV prevention injection is being rolled out at select clinics in SA. View article...

With over 3 600 Western Cape users, lenacapavir is “cool”

From counselling about small nodules to overcoming people's fears of needles, Biénne Huisman takes the pulse of a new HIV prevention injection's ... View article...

Gilead Wins Approval for a Single HIV Tablet Aimed at Patients Taking Handfuls of Pills Each Day

FDA approved Bixlenvo, a once-daily tablet combining bictegravir and lenacapavir for virologically suppressed adults on complex HIV regimens. View article...